Stay updated on Adagrasib Combo in CRC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib Combo in CRC Clinical Trial page.

Latest updates to the Adagrasib Combo in CRC Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a significant revision. The phrase 'Here’s how you know' has been modified, suggesting a change in the presentation or content of information.SummaryDifference1.0%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 10, 2025.SummaryDifference0.7%
- Check36 days agoNo Change Detected
- Check58 days agoChange DetectedThe status of the Phase I Trial of Adagrasib (MRTX849) has changed from 'Recruiting' to 'Active, not recruiting', and the trial's expected completion date has been updated from December 9, 2024, to March 10, 2025.SummaryDifference2%
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check87 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to Adagrasib Combo in CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in CRC Clinical Trial page.